CY1108890T1 - 7-ιμινο παραγωγα καμπτοθεκινης που εχουν αντιογκικη δραση - Google Patents
7-ιμινο παραγωγα καμπτοθεκινης που εχουν αντιογκικη δρασηInfo
- Publication number
- CY1108890T1 CY1108890T1 CY20091100298T CY091100298T CY1108890T1 CY 1108890 T1 CY1108890 T1 CY 1108890T1 CY 20091100298 T CY20091100298 T CY 20091100298T CY 091100298 T CY091100298 T CY 091100298T CY 1108890 T1 CY1108890 T1 CY 1108890T1
- Authority
- CY
- Cyprus
- Prior art keywords
- camptothekin
- producers
- imino
- active
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100001274 therapeutic index Toxicity 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/388,587 US7105492B2 (en) | 1999-03-09 | 2003-03-17 | Camptothecin derivatives having antitumor activity |
| EP04719039A EP1603919B1 (en) | 2003-03-17 | 2004-03-10 | 7-imino derivatives of camptothecin having antitumor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108890T1 true CY1108890T1 (el) | 2014-07-02 |
Family
ID=33029646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100298T CY1108890T1 (el) | 2003-03-17 | 2009-03-17 | 7-ιμινο παραγωγα καμπτοθεκινης που εχουν αντιογκικη δραση |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7105492B2 (https=) |
| EP (1) | EP1603919B1 (https=) |
| JP (1) | JP4791355B2 (https=) |
| KR (1) | KR101174112B1 (https=) |
| CN (1) | CN100372855C (https=) |
| AR (1) | AR043620A1 (https=) |
| AT (1) | ATE417851T1 (https=) |
| AU (1) | AU2004222044B2 (https=) |
| BR (1) | BRPI0408380A (https=) |
| CA (1) | CA2517450C (https=) |
| CY (1) | CY1108890T1 (https=) |
| DE (1) | DE602004018468D1 (https=) |
| DK (1) | DK1603919T3 (https=) |
| ES (1) | ES2319293T3 (https=) |
| PL (1) | PL1603919T3 (https=) |
| PT (1) | PT1603919E (https=) |
| SI (1) | SI1603919T1 (https=) |
| TW (1) | TWI341840B (https=) |
| WO (1) | WO2004083214A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| ITRM20030344A1 (it) * | 2003-07-14 | 2005-01-15 | Ist Naz Stud Cura Dei Tumori | 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi. |
| ITRM20040288A1 (it) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
| CN101080227B (zh) * | 2004-12-15 | 2011-08-31 | 诺瓦提斯公司 | 用于治疗癌症的治疗剂的组合 |
| US7291936B1 (en) * | 2006-05-03 | 2007-11-06 | Robson John H | Submersible electrical power generating plant |
| CN102731516B (zh) * | 2011-04-07 | 2014-07-02 | 宁波天衡药业股份有限公司 | 一类具有抗肿瘤活性的喜树碱衍生物 |
| WO2022140504A1 (en) * | 2020-12-23 | 2022-06-30 | Shanghai Ruotuo Biosciences Co., Ltd. | Antibody-drug conjugates, pharmaceutical compositions, and therapeutic applications |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399276A (en) | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
| JPS58154582A (ja) | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
| ATE247471T1 (de) | 1991-11-15 | 2003-09-15 | Smithkline Beecham Corp | Cisplatin und topotecan enthaltende zusammensetzung als antitumor. |
| US5614529A (en) | 1994-09-22 | 1997-03-25 | Research Triangle Institute | Inhibition of plasmodia parasites by camptothecin compounds |
| US5972955A (en) | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
| IT1282673B1 (it) | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
| KR100516593B1 (ko) | 1996-08-19 | 2005-09-22 | 바이오누머릭 파마슈티칼스, 인코포레이티드 | 고 친유성 캠프토테신 유도체 |
| US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| EP1044977B1 (en) | 1999-03-09 | 2002-05-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Camptothecin derivatives having antitumor activity |
-
2003
- 2003-03-17 US US10/388,587 patent/US7105492B2/en not_active Expired - Fee Related
-
2004
- 2004-03-04 TW TW093105744A patent/TWI341840B/zh not_active IP Right Cessation
- 2004-03-10 DE DE602004018468T patent/DE602004018468D1/de not_active Expired - Lifetime
- 2004-03-10 PT PT04719039T patent/PT1603919E/pt unknown
- 2004-03-10 AU AU2004222044A patent/AU2004222044B2/en not_active Ceased
- 2004-03-10 JP JP2006507637A patent/JP4791355B2/ja not_active Expired - Fee Related
- 2004-03-10 ES ES04719039T patent/ES2319293T3/es not_active Expired - Lifetime
- 2004-03-10 CA CA2517450A patent/CA2517450C/en not_active Expired - Fee Related
- 2004-03-10 US US10/546,211 patent/US7351714B2/en not_active Expired - Fee Related
- 2004-03-10 BR BRPI0408380-6A patent/BRPI0408380A/pt not_active IP Right Cessation
- 2004-03-10 AT AT04719039T patent/ATE417851T1/de active
- 2004-03-10 WO PCT/IT2004/000118 patent/WO2004083214A1/en not_active Ceased
- 2004-03-10 CN CNB2004800071482A patent/CN100372855C/zh not_active Expired - Fee Related
- 2004-03-10 KR KR1020057015243A patent/KR101174112B1/ko not_active Expired - Fee Related
- 2004-03-10 DK DK04719039T patent/DK1603919T3/da active
- 2004-03-10 PL PL04719039T patent/PL1603919T3/pl unknown
- 2004-03-10 EP EP04719039A patent/EP1603919B1/en not_active Expired - Lifetime
- 2004-03-10 SI SI200431027T patent/SI1603919T1/sl unknown
- 2004-03-16 AR ARP040100864A patent/AR043620A1/es not_active Application Discontinuation
-
2009
- 2009-03-17 CY CY20091100298T patent/CY1108890T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR043620A1 (es) | 2005-08-03 |
| KR101174112B1 (ko) | 2012-08-16 |
| AU2004222044A1 (en) | 2004-09-30 |
| WO2004083214A1 (en) | 2004-09-30 |
| HK1089160A1 (zh) | 2006-11-24 |
| CN100372855C (zh) | 2008-03-05 |
| JP4791355B2 (ja) | 2011-10-12 |
| DK1603919T3 (da) | 2009-03-09 |
| US7105492B2 (en) | 2006-09-12 |
| US7351714B2 (en) | 2008-04-01 |
| US20060167033A1 (en) | 2006-07-27 |
| EP1603919A1 (en) | 2005-12-14 |
| PT1603919E (pt) | 2009-02-16 |
| CA2517450C (en) | 2011-06-14 |
| DE602004018468D1 (de) | 2009-01-29 |
| AU2004222044B2 (en) | 2010-02-25 |
| CA2517450A1 (en) | 2004-09-30 |
| TW200504076A (en) | 2005-02-01 |
| US20040018988A1 (en) | 2004-01-29 |
| TWI341840B (en) | 2011-05-11 |
| JP2006520807A (ja) | 2006-09-14 |
| PL1603919T3 (pl) | 2009-06-30 |
| CN1761668A (zh) | 2006-04-19 |
| SI1603919T1 (sl) | 2009-04-30 |
| ATE417851T1 (de) | 2009-01-15 |
| BRPI0408380A (pt) | 2006-03-21 |
| KR20050107756A (ko) | 2005-11-15 |
| ES2319293T3 (es) | 2009-05-06 |
| EP1603919B1 (en) | 2008-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP4008A (xx) | Derivati kamptotecina koji imaju antitumorno dejstvo | |
| CY1113846T1 (el) | Παραγωγα πυριμιδινης για την θεραπευτικη αντιμετωπιση του ασθματος, copd, αλλεργικης ρινιτιδας, αλλεργικης επιπεφυκιτιδας, ατοπικης δερματιτιδας, καρκινου, ηπατιτιδας β, ηπατιτιδας c, hiv, hpv, βακτηριακων λοιμωξεων και δερματωσης | |
| CY1110247T1 (el) | Παραγωγα βενζοκιναζολινης και η χρηση τους στην θεραπεια των διαταραχων των οστων | |
| CY1111739T1 (el) | Πυριδινο[3,4-β]πυραζινονες | |
| CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
| CY1113323T1 (el) | Ενωσεις τετραϋδροφουρο[3,4-d]διοξολανιου για χρηση στη θεραπεια ιικων μολυνσεων και καρκινου | |
| CY1108129T1 (el) | Παραγωγα 4-αμινο-6-φαινυλ-πυρρολο[2,3-δ]πυριμιδινης | |
| CY1108094T1 (el) | Κινολινικα παραγωγα ως αναστολεις φωσφοδιεστερασης | |
| CY1108890T1 (el) | 7-ιμινο παραγωγα καμπτοθεκινης που εχουν αντιογκικη δραση | |
| CY1122863T1 (el) | Φαρμακευτικη συνθεση που περιεχει γλυκοπυρρολικο και εναν αγωνιστη βητα2 αδρενοϋποδοχεα | |
| CY1114708T1 (el) | Παραγωγα πυραζολο-κιναζολινης, διαδικασια για την παρασκευη τους και η χρηση τους ως αναστολεων κινασης | |
| CY1116103T1 (el) | Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης | |
| CY1113209T1 (el) | Νεα παραγωγα πυρρολο [3,2-d] πυριμιδιν-4-ονης και η χρηση τους στη θεραπεια | |
| CY1119381T1 (el) | Παραγωγα 2-μεθυλομορφολινο πυριδο-, πυραζο- και πυριμιδο-πυριμιδινης ως αναστολεις mtor | |
| CY1110254T1 (el) | Φαινυλακεταμιδια και χρησις των ως διαμορφωται γλυκοκινασης | |
| CY1109728T1 (el) | Νεα παραγωγα υδαντοϊνης για τη θεραπεια αποφρακτικων νοσηματων της αναπνευστικης οδου | |
| CY1115227T1 (el) | Νεοι καταστολεις φωσφοδιεστερασης (phosphodiesterase) | |
| CY1108894T1 (el) | Νεα παραγωγα βενζιμιδαζολης | |
| CY1110990T1 (el) | Παραγωγα αδενοσινης ως αγωνιστες υποδοχεων α2α | |
| CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
| CY1105460T1 (el) | Παραγωγα ακετυλενιου που εχουν mlgur 5 ανταγωνιστικη δραση | |
| SE0401342D0 (sv) | Therapeutic compounds | |
| CY1112708T1 (el) | [1η-ινδολο-5-υλο)-ετεροαρυλοξυ]-(1-αζα-δικυκλο[3.3.1]εννεανια ως χολινεργικοι συνδετες του ν-achr για την θεραπεια των ψυχωτικων και νευροεκφυλιστικων διαταραχων | |
| CY1105948T1 (el) | Παραγωγα φαινυλακεταμιδο-θειαζολης, διepγασια για την παρασκευη τους και η χρηση τους ως παραγοντων κατα των ογκων | |
| WO2004018475A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |